Logo image of SSY

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

NYSEARCA:SSY - US86737U1025 - Common Stock

1.115 USD
+0.16 (+16.15%)
Last: 8/14/2025, 8:04:00 PM
1.0701 USD
-0.04 (-4.03%)
After Hours: 8/14/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SSY. SSY was compared to 104 industry peers in the Health Care Providers & Services industry. SSY has a great financial health rating, but its profitability evaluates not so good. SSY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SSY was profitable.
SSY had a negative operating cash flow in the past year.
SSY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SSY reported negative operating cash flow in multiple years.
SSY Yearly Net Income VS EBIT VS OCF VS FCFSSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

SSY has a Return On Assets of 9.87%. This is amongst the best in the industry. SSY outperforms 93.27% of its industry peers.
The Return On Equity of SSY (12.86%) is better than 80.77% of its industry peers.
Industry RankSector Rank
ROA 9.87%
ROE 12.86%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSY Yearly ROA, ROE, ROICSSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 5.55%, SSY is in the better half of the industry, outperforming 79.81% of the companies in the same industry.
SSY has a better Gross Margin (43.05%) than 70.19% of its industry peers.
SSY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.55%
GM 43.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
SSY Yearly Profit, Operating, Gross MarginsSSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
SSY has more shares outstanding than it did 1 year ago.
SSY has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SSY Yearly Shares OutstandingSSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
SSY Yearly Total Debt VS Total AssetsSSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

SSY has an Altman-Z score of 2.88. This is not the best score and indicates that SSY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.88, SSY is doing good in the industry, outperforming 61.54% of the companies in the same industry.
SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.88
ROIC/WACCN/A
WACC8.9%
SSY Yearly LT Debt VS Equity VS FCFSSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

SSY has a Current Ratio of 3.91. This indicates that SSY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SSY (3.91) is better than 88.46% of its industry peers.
A Quick Ratio of 3.50 indicates that SSY has no problem at all paying its short term obligations.
SSY has a Quick ratio of 3.50. This is amongst the best in the industry. SSY outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.5
SSY Yearly Current Assets VS Current LiabilitesSSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.41% over the past year.
Looking at the last year, SSY shows a very negative growth in Revenue. The Revenue has decreased by -12.45% in the last year.
Measured over the past years, SSY shows a decrease in Revenue. The Revenue has been decreasing by -6.58% on average per year.
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSY Yearly Revenue VS EstimatesSSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.29, the valuation of SSY can be described as very cheap.
SSY's Price/Earnings ratio is rather cheap when compared to the industry. SSY is cheaper than 99.04% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, SSY is valued rather cheaply.
Industry RankSector Rank
PE 4.29
Fwd PE N/A
SSY Price Earnings VS Forward Price EarningsSSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSY Per share dataSSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (8/14/2025, 8:04:00 PM)

After market: 1.0701 -0.04 (-4.03%)

1.115

+0.16 (+16.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2025-05-14
Earnings (Next)09-29 2025-09-29
Inst Owners11.33%
Inst Owner Change-10.1%
Ins Owners28.31%
Ins Owner Change-145.48%
Market Cap7.85M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date07-31 2025-07-31 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.29
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)0.26
EY23.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS4.42
BVpS1.9
TBVpS1.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.87%
ROE 12.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.55%
GM 43.05%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score4
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.16%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.5
Altman-Z 2.88
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A